Assessing the generalizability of all-cause mortality from the MOSAIC trial to older adults diagnosed with stage II and III colon cancer in SEER-Medicare (Generalizability of colon cancer trial results)First published 17/01/2018 Last updated 02/04/2024 EU PAS number: EUPAS22355StudyOngoing